Contact Information
Company Information
Total Funding
327113998.0
Professional Summary
Tim Knotnerus serves as CEO at Agomab. Agomab operates in the research sector with approximately 68.0 employees. The company is headquartered in Amsterdam, Noord-Holland. Agomab generates annual revenue of 5000000.0. To date, Agomab has raised 327113998.0 in total funding, with the most recent round being Series D.
Industry & Role Insights
-
•
MessageCEO tracks 2,961 executives in the research sector.
-
•
We have verified contacts for 2 executives at Agomab.
-
•
324 executive contacts are available in Noord-Holland.
-
•
Our database includes 201,469 c suite-level executives.
Technologies
Outlook
Microsoft Azure Hosting
Microsoft-IIS
Mobile Friendly
ASP.NET
Woo Commerce
WordPress.org
Google Tag Manager
reCAPTCHA
Bootstrap Framework
Google Maps (Non Paid Users)
Google Maps
Google Font API
AI
Keywords
biotechnology research
growth factor therapy
fibrosis treatment
alk5 inhibitor
tgf beta signaling
hepatocyte growth factor
fgf modulation
regenerative medicine
clinical pipeline
cells regeneration
oral small molecule
inhaled treatment
idiopathic pulmonary fibrosis
crohn's disease therapy
disease-modifying treatment
preclinical studies
biotech innovation
clinical trials
fibrotic diseases
organ function restoration
small molecule drugs
monoclonal antibodies
expanding pipeline
biotherapeutics
fibrosis resolution
organ-restricted therapy
immunotherapy development
gastrointestinal diseases
phase 1 clinical trial
phase 2 clinical trial
systemic exposure prevention
local concentration targeting
innovative r&d
advanced drug development
tissue repair
molecular pathways modulation
fda orphan drug designation
series financing
venture capital support
biotech partnerships
scientific collaboration
met receptor agonism
indication expansion
progressive organ failure treatment
equity financing
research & development
biomarker identification
clinical efficacy
safety profile
patient improvement strategies
research expertise
health care
health
wellness & fitness
hospital & health care
Related Executives
Outreach Guidance — research Sector
Executives like Tim Knotnerus in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Agomab.
Tim Knotnerus's Position in the MessageCEO Database
- •Tim Knotnerus is 1 of 2 verified executive contacts we track at Agomab.
- •2,871 verified executive contacts in research are in the MessageCEO database.
- •323 verified executive contacts in Noord-Holland are in the database.
- •25 verified contacts work at research companies in the 68.0 employee range (same size as Agomab).
Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated May 2026.
Frequently Asked Questions
How do I reach Tim Knotnerus directly?
Tim Knotnerus's verified email address is available to MessageCEO Pro subscribers. They currently serve as CEO at Agomab. Access direct contact info to skip gatekeepers and reach the decision maker.
What company does Tim Knotnerus work for?
Tim Knotnerus is CEO at Agomab, a company in the research sector with 68.0 employees. The company is based in Amsterdam, Noord-Holland.
Can I pitch or sell to Tim Knotnerus?
As CEO at Agomab, Tim Knotnerus is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Tim Knotnerus directly — ideal for B2B sales, partnerships, and executive recruiting.
What industry is Tim Knotnerus in?
Tim Knotnerus works in the research industry as CEO at Agomab. MessageCEO provides verified contact information for executives across all major industries.
Is Tim Knotnerus's contact information verified?
Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Tim Knotnerus's profile is kept up-to-date with the latest available information.
Last updated: May 30, 2026
Get Full Contact Details
Subscribe to reveal email addresses and export contacts.
View Plans